West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Financials

SEC Filings

Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
3.220B844.900M805.000M804.300M766.200M698.200M748.500M746.900M702.000M
Cost of Goods Sold
2.053B548.500M501.100M510.800M493.000M465.500M474.100M481.700M470.700M
1.167B296.400M303.900M293.500M273.200M232.700M274.400M265.200M231.300M
35.1%35.1%37.8%36.5%35.7%33.3%36.7%35.5%32.9%
Total Operating Expenses
500.900M119.300M146.800M119.800M115.000M104.300M103.800M97.400M100.500M
73.800M15.800M21.800M17.100M19.100M16.300M18.500M15.500M17.500M
404.600M99.500M106.500M102.700M95.900M88.000M85.300M81.900M83.000M
665.600M177.100M156.600M173.700M158.200M128.400M170.600M167.800M130.800M
21.0%21.0%19.5%21.6%20.6%18.4%22.8%22.5%18.6%
681.500M180.100M165.400M174.000M162.000M113.900M166.900M168.400M133.200M
Interest Income
16.800M3.200M5.300M4.700M3.600M4.100M4.800M4.600M4.000M
200K100K100K400K700K1.500M
Other Income/Expense
15.900M3.000M8.800M300K3.800M-14.500M-3.700M600K2.400M
542.700M138.800M132.100M140.000M131.800M89.800M130.100M136.000M111.300M
142.200M44.700M33.300M34.000M30.200M24.100M36.800M32.400M21.900M
16.4%16.4%16.4%17.4%17.2%12.9%17.4%18.2%15.9%
841.600M221.700M203.600M216.700M199.600M168.400M211.300M208.000M169.700M
26.2%26.2%25.3%26.9%26.1%24.1%28.2%27.8%24.2%
176.000M44.600M47.000M43.000M41.400M40.000M40.700M40.200M38.900M
7.521.931.831.941.821.241.791.871.52
7.491.921.821.931.821.231.781.851.51
72.000M72.000M72.300M72.300M72.300M72.500M73.000M72.800M73.000M
72.400M72.400M72.700M72.700M72.800M73.000M73.700M73.400M73.700M

Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
3.074B2.893B2.951B2.885B2.831B2.147B1.844B1.718B
Cost of Goods Sold
1.970B1.891B1.818B1.747B1.657B1.379B1.235B1.172B
1.103B1.002B1.133B1.139B1.173B767.900M608.800M546.300M
35.9%34.6%38.4%39.5%41.5%35.8%33.0%31.8%
Total Operating Expenses
485.900M407.600M421.800M375.400M414.700M348.900M311.600M291.500M
74.300M69.100M68.400M58.500M52.800M46.900M38.900M40.300M
393.100M338.500M353.400M316.900M361.900M302.000M272.700M262.900M
617.400M594.600M710.900M763.500M758.700M419.000M297.200M254.800M
20.1%20.6%24.1%26.5%26.8%19.5%16.1%14.8%
615.300M600.200M715.700M700.600M769.000M418.700M300.700M248.300M
Interest Income
17.700M19.600M28.000M5.100M1.000M1.400M3.800M2.100M
600K2.900M8.800M7.600M8.500M8.500M8.000M8.100M
Other Income/Expense
-2.100M5.600M4.800M-62.900M10.300M-300K3.500M-6.500M
493.700M492.700M593.400M585.900M661.800M346.200M241.700M206.900M
121.600M107.500M122.300M114.700M107.200M72.500M59.000M41.400M
16.1%17.0%20.1%20.3%23.4%16.1%13.1%12.0%
741.800M750.000M848.200M884.100M881.000M528.100M400.600M359.200M
24.1%25.9%28.7%30.6%31.1%24.6%21.7%20.9%
124.400M155.400M137.300M120.600M122.300M109.100M103.400M104.400M
6.836.757.997.888.904.683.272.80
6.806.697.887.738.674.573.212.74
72.300M73.000M74.300M74.400M74.400M73.900M74.000M73.900M
72.700M73.700M75.300M75.800M76.300M75.800M75.400M75.400M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green